DK0734730T3 - Anvendelse af en CGRP-antagonist til behandling af øjen- eller øjenlågskløe og -dysæstesier - Google Patents

Anvendelse af en CGRP-antagonist til behandling af øjen- eller øjenlågskløe og -dysæstesier

Info

Publication number
DK0734730T3
DK0734730T3 DK96400459T DK96400459T DK0734730T3 DK 0734730 T3 DK0734730 T3 DK 0734730T3 DK 96400459 T DK96400459 T DK 96400459T DK 96400459 T DK96400459 T DK 96400459T DK 0734730 T3 DK0734730 T3 DK 0734730T3
Authority
DK
Denmark
Prior art keywords
eyelid
dysesthesia
itching
treat
cgrp antagonist
Prior art date
Application number
DK96400459T
Other languages
English (en)
Inventor
Lacharriere Olivier De
Lionel Breton
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of DK0734730T3 publication Critical patent/DK0734730T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96400459T 1995-03-28 1996-03-04 Anvendelse af en CGRP-antagonist til behandling af øjen- eller øjenlågskløe og -dysæstesier DK0734730T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9503629A FR2732222B1 (fr) 1995-03-28 1995-03-28 Utilisation d'un antagoniste de cgrp pour le traitement des prurits et des dysesthesies oculaires et palpebraux

Publications (1)

Publication Number Publication Date
DK0734730T3 true DK0734730T3 (da) 2001-12-17

Family

ID=9477499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96400459T DK0734730T3 (da) 1995-03-28 1996-03-04 Anvendelse af en CGRP-antagonist til behandling af øjen- eller øjenlågskløe og -dysæstesier

Country Status (15)

Country Link
US (2) US6169069B1 (da)
EP (1) EP0734730B1 (da)
JP (1) JP3024064B2 (da)
AR (1) AR002975A1 (da)
AT (1) ATE205089T1 (da)
BR (1) BR9601461A (da)
CA (1) CA2172779C (da)
DE (1) DE69614907T2 (da)
DK (1) DK0734730T3 (da)
ES (1) ES2163596T3 (da)
FR (1) FR2732222B1 (da)
HU (1) HUP9600766A3 (da)
MX (1) MX9601149A (da)
PL (1) PL313513A1 (da)
RU (1) RU2155601C2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081241B1 (en) * 1998-10-06 2006-07-25 The Trustees Of Columbia University In The City Of New York Extracellular rage binding protein (EN-RAGE) and uses thereof
US7112334B2 (en) * 2001-06-05 2006-09-26 Freiberg Roberta C Allergy inhibition
US20040038861A1 (en) * 2001-11-26 2004-02-26 Cooper Garth J. S. Methods and compositions for normalizing lipid levels in mammalian tissues
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
BRPI0618705B8 (pt) 2005-11-14 2021-05-25 Labrys Biologics Inc anticorpos antagonistas humanizados direcionados contra peptídeo relacionado ao gene da calcitonina, composição farmacêutica e uso dos mesmos
EP2265287B1 (en) * 2008-03-04 2018-09-05 Teva Pharmaceuticals International GmbH Methods of treating chronic pain
EP2470207A1 (en) 2009-08-28 2012-07-04 Rinat Neuroscience Corporation Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
EA201400064A1 (ru) * 2011-06-28 2014-05-30 Байер Хелфкеэ Ллк Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб
EP3089748A4 (en) 2014-01-02 2017-09-27 Massachusetts Eye & Ear Infirmary Treating ocular neovascularization
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
JP6568099B2 (ja) 2014-03-21 2019-08-28 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーＴｅｖａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ カルシトニン遺伝子関連ペプチドに対するアンタゴニスト抗体及びその使用方法
KR20220031944A (ko) 2016-09-23 2022-03-14 테바 파마슈티컬스 인터내셔널 게엠베하 불응성 편두통의 치료

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201425D0 (sv) * 1992-05-06 1992-05-06 Kabi Pharmacia Ab Method and means for preventing constriction of the pupil in the eye

Also Published As

Publication number Publication date
EP0734730A1 (fr) 1996-10-02
US6344438B1 (en) 2002-02-05
DE69614907T2 (de) 2002-01-17
RU2155601C2 (ru) 2000-09-10
MX9601149A (es) 1997-08-30
US6169069B1 (en) 2001-01-02
FR2732222B1 (fr) 1997-04-25
CA2172779C (fr) 2001-12-25
FR2732222A1 (fr) 1996-10-04
ES2163596T3 (es) 2002-02-01
JPH08268913A (ja) 1996-10-15
ATE205089T1 (de) 2001-09-15
EP0734730B1 (fr) 2001-09-05
CA2172779A1 (fr) 1996-09-29
PL313513A1 (en) 1996-09-30
JP3024064B2 (ja) 2000-03-21
DE69614907D1 (de) 2001-10-11
HUP9600766A3 (en) 1998-04-28
AR002975A1 (es) 1998-05-27
BR9601461A (pt) 1998-03-31
HU9600766D0 (en) 1996-05-28
HUP9600766A2 (en) 1997-06-30

Similar Documents

Publication Publication Date Title
DK0734729T3 (da) Anvendelse af en CGRP-antagonist til behandling af hudrødme af neurogen oprindelse og den opnåede sammensætning
FR2661475B1 (fr) Combinaison de vilebrequin et de volant d'inertie.
DK0734730T3 (da) Anvendelse af en CGRP-antagonist til behandling af øjen- eller øjenlågskløe og -dysæstesier
LV11465A (lv) Heterocikliski amidini panemiens to iegusanai un pielietojums
PT744437E (pt) Misturas de compostos de organossilano e sua utilizacao
FR2732220B1 (fr) Utilisation d'un antagoniste de cgrp pour traiter les lichens et les prurits et composition obtenue
KR950701022A (ko) 부직포웹의 후처리 방법(Post-treatment of nonwoven webs)
DE69613041T2 (de) Verwendung von Erdalkalimetallsalzen zur Behandlung von okularem oder palpebralem Juckreiz und okularer oder palpebraler Dysästhesie
DE69124145T2 (de) Bauwerk und Aufbaumethode
DK0839033T3 (da) Anvendelse af L-carnitin og derivater til reducering af ceramidniveauer og potensering af antiretroviral virkning
NO924219D0 (no) Konstruksjon bestaaende av primaer- og sekundaerkonstruksjoner
KR920007957U (ko) 비탈면 수로 겸용 보호블럭
KR960008277U (ko) 슬라브개구부의 낙하방지구조
SE9002524D0 (sv) Anordning vid svarvstaal
DE29505190U1 (de) Als Umhang verwendbares Bade- und Liegetuch
SE9001689D0 (sv) Bad- och duschanordning
SE9001690D0 (sv) Dusch- och badanordning
SE9000294D0 (sv) Bad- och duschanordning
SE9000411D0 (sv) Dusch- och badanordning
SE9302188D0 (sv) Anordning vid saeng och faatoelj
BR9102975A (pt) Conjunto de chuveiro portatil e chuveiro
KR920002719U (ko) 수로겸용 비탈면 보호블록
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije
SE9300397D0 (sv) Saett och anordning foer att foerhindra oljeutslaepp
DE29518469U1 (de) Bade- und Duschvorrichtung